HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis (Q36435134)

14 August 2017

HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. (English)

1 reference

juvenile rheumatoid arthritis

14 August 2017

1 reference

52

Eleftheria Zeggini

1 reference

14 August 2017

Joanna Cobb

27

0 references

Michael J. Ombrello

Michael J Ombrello

1

0 references

Dalila Pinto

Dalila Pinto

37

0 references

Anne Hinks

Anne Hinks

24

0 references

Rae S M Yeung

Rae S M Yeung

19

0 references

Ricardo Russo

Ricardo Russo

15

0 references

Leah C. Kottyan

Leah C Kottyan

36

0 references

Elaine F. Remmers

Elaine F Remmers

2

0 references

Jordi Anton

Jordi Anton

22

0 references

Wendy Thomson

Wendy Thomson

Xavier Estivill i Pallejà

53

0 references

Xavier Estivill

41

0 references

Richard Duerr

Richard H Duerr

32

0 references

Lucy R Wedderburn

Lucy R Wedderburn

21

0 references

Stephen W. Scherer

38

Stephen W Scherer

1 reference

14 August 2017

Marta E Alarcón-Riquelme

39

Marta E Alarcón-Riquelme

1 reference

14 August 2017

54

Daniel L Kastner

1 reference

14 August 2017

8

Marco Gattorno

1 reference

14 August 2017

50

Carl D Langefeld

1 reference

14 August 2017

29

Buhm Han

1 reference

14 August 2017

9

Seza Özen

1 reference

14 August 2017

3

Ioanna Tachmazidou

1 reference

14 August 2017

4

Alexei Grom

1 reference

14 August 2017

5

Dirk Foell

1 reference

14 August 2017

6

Johannes-Peter Haas

1 reference

14 August 2017

10

Sampath Prahalad

1 reference

14 August 2017

11

Andrew S Zeft

1 reference

14 August 2017

12

John F Bohnsack

1 reference

14 August 2017

13

Elizabeth D Mellins

1 reference

14 August 2017

14

Norman T Ilowite

1 reference

14 August 2017

16

Claudio Len

1 reference

Maria Odete Esteves Hilário

14 August 2017

17

Maria Odete E Hilario

1 reference

14 August 2017

20

Alan Rosenberg

1 reference

14 August 2017

30

Elizabeth Baskin

1 reference

14 August 2017

31

Sara Signa

1 reference

14 August 2017

34

M Ilyas Kamboh

1 reference

14 August 2017

40

Elisa Docampo

1 reference

14 August 2017

42

Ahmet Gül

1 reference

14 August 2017

55

Patricia Woo

1 reference

14 August 2017

51

Susan Thompson

1 reference

14 August 2017

Alberto Martini

7

1 reference

14 August 2017

Sheila Oliveira

18

1 reference

14 August 2017

Tobias Schwarz

23

1 reference

14 August 2017

Yelda Bilginer

25

1 reference

14 August 2017

Jane Park

26

1 reference

14 August 2017

Colleen L Satorius

28

1 reference

14 August 2017

J P Achkar

33

1 reference

14 August 2017

Kenneth M Kaufman

35

1 reference

14 August 2017

British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group

43

1 reference

14 August 2017

Childhood Arthritis Prospective Study (CAPS) Group

44

1 reference

14 August 2017

Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators

45

1 reference

14 August 2017

Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group

46

1 reference

14 August 2017

Biologically Based Outcome Predictors in JIA (BBOP) Group

47

1 reference

14 August 2017

Paul I W de Bakker

48

1 reference

14 August 2017

Soumya Raychaudhuri

49

1 reference

14 August 2017

International Childhood Arthritis Genetics (INCHARGE) Consortium

56

1 reference

14 August 2017

language of work or name

English

0 references

publication date

23 November 2015

1 reference

Proceedings of the National Academy of Sciences of the United States of America

14 August 2017

1 reference

14 August 2017

112

1 reference

14 August 2017

52

1 reference

14 August 2017

15970-15975

1 reference

Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

Prevalence and incidence of juvenile idiopathic arthritis: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

Systemic juvenile idiopathic arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

Hierarchy of risk of childhood-onset rheumatoid arthritis conferred by HLA-DRB1 alleles encoding the shared epitope

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

Activation of MyD88 signaling upon staphylococcal enterotoxin binding to MHC class II molecules

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

MHC class II molecules activate NFAT and the ERK group of MAPK through distinct signaling pathways in B cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

MHC class II proteins and disease: a structural perspective

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

Transcriptional activation of IL-1 beta and tumor necrosis factor-alpha genes by MHC class II ligands

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4702958

The Systemic-Onset Variant of Juvenile Idiopathic Arthritis Needs to Be Recorded as an Autoinflammatory Syndrome: Comment on the Review by Nigrovic

28 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1520779112

Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients

21 January 2018

1 reference

12 December 2020

Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes

1 reference

12 December 2020

HLA gene frequencies in children and adults with systemic onset juvenile rheumatoid arthritis

1 reference

12 December 2020

Increased frequency of DR4 in systemic onset juvenile chronic arthritis

1 reference

12 December 2020

Major histocompatibility complex markers and disease heterogeneity in one hundred eight patients with systemic onset juvenile chronic arthritis

1 reference

12 December 2020

A mixed Th1/Th2 cell cytokine response predominates in systemic onset juvenile rheumatoid arthritis: immunoregulatory IL-10 function

1 reference

12 December 2020

Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.1520779112

1 reference

14 August 2017

0 references

1 reference

14 August 2017

1 reference